CY1105127T1 - Συνθεση για την προληψη καρδιαγγειακων νοσων - Google Patents
Συνθεση για την προληψη καρδιαγγειακων νοσωνInfo
- Publication number
- CY1105127T1 CY1105127T1 CY20061101104T CY061101104T CY1105127T1 CY 1105127 T1 CY1105127 T1 CY 1105127T1 CY 20061101104 T CY20061101104 T CY 20061101104T CY 061101104 T CY061101104 T CY 061101104T CY 1105127 T1 CY1105127 T1 CY 1105127T1
- Authority
- CY
- Cyprus
- Prior art keywords
- composition
- prevention
- cardiac diseases
- present
- cardiovascular diseases
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 4
- 208000019622 heart disease Diseases 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μία μέθοδο για την πρόληψη καρδιαγγειακών νόσων, σε μία σύνθεση για την πρόληψη καρδιαγγειακών νόσων, στη χρήση συγκεκριμένων δραστικών συστατικών για την παραγωγή μίας τέτοιας συνθέσεως για χρήση στη μέθοδο και σε μία μέθοδο παρασκευής της εν λόγω συνθέσεως. Η σύνθεση της παρούσης εφευρέσεως είναι ένας συνδυασμός δραστικών παραγόντων για χρήση στην πρόληψη καρδιαγγειακών νόσων, ιδιαίτερα της καρδιακής ισχαιμίας (περιλαμβανομένων καρδιακών προσβολών) και των εγκεφαλικών στο σύνολο του ενήλικου πληθυσμού.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0008791A GB2361185A (en) | 2000-04-10 | 2000-04-10 | Pharmaceutical formulation for the prevention of cardiovascular disease |
GB0100548A GB2361186B (en) | 2000-04-10 | 2001-01-09 | Formulation for the prevention of cardiovascular disease |
PCT/GB2001/001618 WO2001076632A1 (en) | 2000-04-10 | 2001-04-10 | Formulation for the prevention of cardiovascular disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105127T1 true CY1105127T1 (el) | 2009-11-04 |
Family
ID=26244072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101104T CY1105127T1 (el) | 2000-04-10 | 2006-08-07 | Συνθεση για την προληψη καρδιαγγειακων νοσων |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1272220B2 (el) |
AT (1) | ATE326240T2 (el) |
AU (1) | AU4671101A (el) |
CA (1) | CA2406077C (el) |
CY (1) | CY1105127T1 (el) |
DE (1) | DE60119715T3 (el) |
DK (1) | DK1272220T4 (el) |
ES (1) | ES2263604T5 (el) |
PT (1) | PT1272220E (el) |
WO (1) | WO2001076632A1 (el) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
DE10222326A1 (de) * | 2002-05-16 | 2003-12-04 | Hexal Ag | Stabile pharmazeutische Formulierung für eine Kombination aus einem Statin mit einem ACE-Hemmer |
PL377344A1 (pl) | 2003-01-31 | 2006-01-23 | Sankyo Company, Limited | Lekarstwo do profilaktyki i leczenia miażdżycy tętnic i nadciśnienia |
EP1648422A4 (en) * | 2003-07-28 | 2007-09-19 | Reddys Lab Inc Dr | TREATMENT AND PREVENTION OF CARDIOVASCULAR ACCIDENTS |
EP2275106A1 (en) | 2005-09-15 | 2011-01-19 | Otsuka Pharmaceutical Co., Ltd. | Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
US20070185065A1 (en) * | 2006-02-03 | 2007-08-09 | Vikramjit Chhokar | Combination therapy for coronary artery disease |
ES2300188B1 (es) * | 2006-05-24 | 2009-05-01 | Ferrer Internacional, S.A. | Comprimido bicapa para la prevencion de los accidentes cardiovasculares. |
MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CN101590240B (zh) * | 2008-05-30 | 2012-04-25 | 北京奥萨医药研究中心有限公司 | 含血管紧张素ⅱ受体拮抗剂、他汀和叶酸的组合物及用途 |
CN101590239B (zh) * | 2008-05-30 | 2013-03-27 | 北京奥萨医药研究中心有限公司 | 含有利尿剂、他汀和叶酸的药物组合物及其用途 |
ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9789187B2 (en) | 2009-02-11 | 2017-10-17 | Cadila Pharmaceuticals Limited | Stable pharmaceutical composition for atherosclerosis |
EP2958577A2 (en) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
US10369156B2 (en) | 2016-11-15 | 2019-08-06 | The George Institute for Global Health | Compositions for the treatment of hypertension |
JP2020506180A (ja) | 2017-01-25 | 2020-02-27 | ザ ジョージ インスティテュート フォー グローバル ヘルス | 高血圧症の処置のための組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948443A (en) † | 1996-02-23 | 1999-09-07 | Medical Doctor's Research Institute, Inc. | Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease |
AU732465B2 (en) * | 1996-04-17 | 2001-04-26 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
EP0946178A4 (en) * | 1996-09-18 | 2003-05-07 | Merck & Co Inc | COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES |
US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
US6054128A (en) † | 1997-09-29 | 2000-04-25 | Wakat; Diane | Dietary supplements for the cardiovascular system |
-
2001
- 2001-04-10 AU AU46711/01A patent/AU4671101A/en not_active Abandoned
- 2001-04-10 WO PCT/GB2001/001618 patent/WO2001076632A1/en active IP Right Grant
- 2001-04-10 EP EP01919650.0A patent/EP1272220B2/en not_active Expired - Lifetime
- 2001-04-10 CA CA2406077A patent/CA2406077C/en not_active Expired - Fee Related
- 2001-04-10 ES ES01919650.0T patent/ES2263604T5/es not_active Expired - Lifetime
- 2001-04-10 DK DK01919650.0T patent/DK1272220T4/en active
- 2001-04-10 PT PT01919650T patent/PT1272220E/pt unknown
- 2001-04-10 DE DE60119715.1T patent/DE60119715T3/de not_active Expired - Lifetime
- 2001-04-10 AT AT01919650T patent/ATE326240T2/de active
-
2006
- 2006-08-07 CY CY20061101104T patent/CY1105127T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2406077C (en) | 2010-07-20 |
ES2263604T3 (es) | 2006-12-16 |
DE60119715D1 (de) | 2006-06-22 |
ES2263604T5 (es) | 2017-02-07 |
ATE326240T2 (de) | 2006-06-15 |
DK1272220T3 (da) | 2006-09-25 |
DK1272220T4 (en) | 2016-11-28 |
DE60119715T2 (de) | 2007-03-15 |
EP1272220A1 (en) | 2003-01-08 |
DE60119715T3 (de) | 2016-12-08 |
EP1272220B1 (en) | 2006-05-17 |
EP1272220B2 (en) | 2016-07-27 |
WO2001076632A1 (en) | 2001-10-18 |
CA2406077A1 (en) | 2001-10-18 |
PT1272220E (pt) | 2006-10-31 |
AU4671101A (en) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105127T1 (el) | Συνθεση για την προληψη καρδιαγγειακων νοσων | |
BR0312549A (pt) | Derivados de indolin-fenilsulfonamida | |
BG66080B1 (bg) | Заместени тиоацетамиди | |
ZA200305412B (en) | 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical. | |
EE05419B1 (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
DK1307227T3 (da) | Farmaceutiske sammensætninger | |
DE60131569D1 (de) | Genetisch veränderter herpes virus für die behandlung von herz- und gefässerkrankungen | |
EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
EA200400399A1 (ru) | Способы лечения легочных заболеваний | |
BR0012291A (pt) | Fenoxifluorpirimidinas | |
DOP2002000451A (es) | Nuevas ciclohexilsulfonas (agentes terapéuticos) | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
ATE427938T1 (de) | Herstellung von dibenzoab,fuazepine zwischenprodukte | |
MX9202366A (es) | Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion. | |
TR199900523T2 (xx) | Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler. | |
TR199700963T1 (xx) | Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi. | |
NO20030081L (no) | Anvendelse av stammer fra parapoxvirus mot organfibroser | |
CY1105432T1 (el) | Χρησεις της θαλιπορφινης ή των παραγωγων της στην αγωγη καρδιακων νοσηματων και παρασκευασμα της | |
ATE257144T1 (de) | OMEGA KETTENMODIFIZIERTE HYDROXYEICOSATETRAENSÄURE DERIVATE VERWENDBAR IN DER BEHANDLUNG DER ßTROCKENES AUGEß KRANKHEIT | |
DE50210639D1 (de) | Riechstoffmischungen mit gesteigerter geruchstärke | |
CY1111290T1 (el) | Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης | |
FR2860234B1 (fr) | Nouveaux derives 666 du thioxylose | |
UY26930A1 (es) | Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso | |
ATE247649T1 (de) | Disubstituierte biphenyloxazoline | |
UY27475A1 (es) | Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización |